Carcinogens
FDA advises recall of diabetes drug metformin over carcinogen concerns
May 29, 2020Medical Communications Carcinogens, MDMA
The FDA has asked that multiple pharmaceutical companies recall the formulations of their diabetes drug metformin after the regulatory body …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
